Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Agilon HealthAGL -4.69%73 14-Day RSI is 56.53 as of Jul. 23, 2026. GuruFocus rates AGL with a GF Score™ of 73/100 and a GF Value™ of $94.28 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 695 Healthcare Providers & Services companies, Agilon Health ranks worse than 76.98% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-23), Agilon Health's 14-Day RSI is 56.53.
The industry rank for Agilon Health's 14-Day RSI or its related term are showing as below:
AGL's 14-Day RSI is ranked worse than 76.98% of 695
companies
in the Healthcare Providers & Services industry
Industry Median: 47.56
vs AGL: 56.53
Agilon Health (NYSE:AGL) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Agilon Health 14-Day RSI Related Terms
AGL vs MD, SEM, SGRY: 14-Day RSI Comparison
For the Medical Care Facilities subindustry, Agilon Health's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilon Health 14-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Agilon Health's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Agilon Health's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilon Health (AGL) has a 14-Day RSI of 56.53 as of Jul. 23, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Agilon Health and its competitors. According to the industry distribution chart, Agilon Health ranks #535 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 77%.
Is Agilon Health's 14-Day RSI too high?
Agilon Health's current 14-Day RSI is 56.53. The Healthcare Providers & Services industry median 14-Day RSI is 47.56. Agilon Health's value of 56.53 is 18.9% above this industry median. Based on the distribution chart, Agilon Health ranks #535 out of 695 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Agilon Health has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Agilon Health's 14-Day RSI compare to MD and SEM?
According to the Healthcare Providers & Services industry distribution chart, Agilon Health ranks #535 out of 695 companies for 14-Day RSI. This places Agilon Health in the lower half of its industry. The industry median 14-Day RSI is 47.56. Agilon Health's value of 56.53 is 18.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Healthcare Providers & Services company?
The median 14-Day RSI among Healthcare Providers & Services companies is 47.56, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Agilon Health's current 14-Day RSI of 56.53 is 18.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Agilon Health and its competitors. For the Healthcare Providers & Services industry, the median 14-Day RSI is 47.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Agilon Health's current 14-Day RSI is 56.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilon Health stock overvalued right now?
Based on GuruFocus' analysis, Agilon Health (AGL) is currently considered Modestly Overvalued. The stock's GF Value™ is $94.28, compared to a current price of $119.88 — trading 27.2% above its estimated fair value. The current 14-Day RSI is 56.53 and 18.9% above the Healthcare Providers & Services industry median of 47.56. Agilon Health's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Agilon Health (AGL), the current 14-Day RSI is 56.53 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Agilon Health (AGL) Overvalued in 2026?
Based on GuruFocus' analysis, Agilon Health stock appears to be overvalued.
The current stock price of $119.88 is trading 27.2% above its estimated GF Value™ of $94.28.
GuruFocus considers Agilon Health to be Modestly Overvalued.
Key valuation signals for AGL:
14-Day RSI: 56.53
GF Value™: $94.28 vs. price of $119.88 (27.2% above fair value)
Industry Position: 18.9% above the Healthcare Providers & Services median (#535 of 695)
No single metric tells the full story. See the AGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
73GF Score
Get the complete analysis for AGL
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AGL has been successfully added to your 
